We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Efficacy and Safety Study of Palovarotene for the Treatment of FOP

This study is currently recruiting participants.
Verified October 2017 by Clementia Pharmaceuticals Inc.
Sponsor:
ClinicalTrials.gov Identifier:
NCT03312634
First Posted: October 18, 2017
Last Update Posted: November 30, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Clementia Pharmaceuticals Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2020
  Estimated Primary Completion Date: September 2020 (Final data collection date for primary outcome measure)